Sentinel lymph node biopsy (SLNB) has evolved as a safe alternative for staging of the axilla
in patients with clinically node-negative breast cancer. The sentinel node is most often …

Sentinel lymph node biopsy (SLNB) is a less invasive alternative to axillary lymph node
dissection (ALND) for staging breast cancer. In appropriate women, this procedure can …

Addressal of axilla is an essential part of the management of breast cancer. Routine axillary
lymph node dissection for node negative axillae is no longer performed on account of no …

The axilla has long been a focus of clinicians' attention in the management of breast cancer.
The approach to the axilla has undergone dramatic changes over the last century, from …

Background: Sentinel lymph node biopsy (SLNB) has become a standard diagnostic tool for
axillary staging of breast cancer and has many advantages in comparison with axillary …

Sentinel lymph node biopsy (SLNB) emerged in the 1990s as a new technique in the
surgical management of the axilla for patients with early breast cancer, resulting in lower …

The sentinel lymph node (SLN) is the first lymph node to receive lymphatic drainage from a
tumor. SLN biopsy has become a mainstay of breast cancer management and is used when …

Background Sentinel lymphadenectomy has replaced axillary lymph node dissection as a
staging tool in early breast cancer. To be accepted as a standard of care, it had to pass …

Sentinel Lymph node biopsy (SLNB) represents the standard approach in a newly
diagnosed breast cancer for axillary staging in cases of clinical node negative. This …

Axillary node status is the most important prognostic indicator for patients with invasive
breast cancer. Sentinel lymph-node biopsy (SLNB) is widely accepted and the preferred …